{"url_path":"/sec/byah/10-k/2026/item-9","section_key":"item-9","section_title":"Item 9 THE OFFER AND LISTING**","topic":"sec","document":{"doc_type":"20-F/A","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1986247/0001213900-26-057152-index.html","accession_number":"0001213900-26-057152","cik":"0001986247","ticker":"BYAH","issuer_name":"Park Ha Biological Technology Co., Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1986247/0001213900-26-057152-index.html","primary_entity_key":"0001986247","primary_entity_name":"Park Ha Biological Technology Co., Ltd."},"word_count":72,"has_tables":true,"body_markdown":"**ITEM\n9. THE OFFER AND LISTING**\n\n \n\n**A.\nOffer and listing details**\n\n \n\nOur\nOrdinary Shares have been listed on the Nasdaq Capital Market under the symbol “PHH.” The Ordinary Shares began trading on\nDecember 27, 2024 on the Nasdaq Capital Market.\n\n \n\n**B.\nPlan of distribution**\n\n \n\nNot\napplicable.\n\n \n\n**C.\nMarkets**\n\n \n\nSee\n“— A. Offer and Listing Details” above.\n\n \n\n**D.\nSelling shareholders**\n\n \n\nNot\napplicable.\n\n \n\n**E.\nDilution**\n\n \n\nNot\napplicable.\n\n \n\n**F.\nExpenses of the issue**\n\n \n\nNot\napplicable."}